Publications
29
Citations
1,173
Est. group size
—
Recurring co-author estimate
Active years
22
Publishing since 2004
Aaron E. Lottes's work focuses on the study of peripheral artery disease treatment, particularly drug-eluting stents used to open narrowed leg arteries (femoropopliteal disease). Much of the research involves large clinical trials and post-market surveillance studies (such as the Zilver PTX studies) that track long-term safety, effectiveness, and mortality outcomes of these devices, along with broader work on medical device regulatory science and clinical trial design.
Publication output rose to a peak around 2020-2021 and has since slowed considerably, with little to no output in the most recent years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Global Medical Device Clinical Trials Involving Both the United States and Japan: Key Considerations for Development, Regulatory Approval, and Conduct
Cardiovascular revascularization medicine · 2023
- First peripheral drug-eluting stent clinical results from China: 1-year outcomes of the Zilver PTX China study
Frontiers in Cardiovascular Medicine · 2022
- Vascular Quality Initiative Surveillance of Femoropopliteal Artery Paclitaxel Devices
JACC: Cardiovascular Interventions · 2021
- 81007 Training Biomedical Engineers in Regulatory Science: Critical Role of Experts from Industry and FDA
Journal of Clinical and Translational Science · 2021
- Long-Term Effectiveness of a Drug-Eluting Stent for Femoropopliteal In-Stent Restenosis: Subanalysis of the Zilver PTX Japan Post-Market Surveillance Study
Journal of Endovascular Therapy · 2020
- Prediction Model for Freedom from TLR from a Multi-study Analysis of Long-Term Results with the Zilver PTX Drug-Eluting Peripheral Stent
CardioVascular and Interventional Radiology · 2020
- Important considerations for trials for peripheral arterial disease: Lessons learned from the paclitaxel mortality signal: A report on behalf of the registry assessment for peripheral interventional Devices (RAPID) Paclitaxel Pathways Program
American Heart Journal · 2020
- Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions
Journal of Vascular Surgery · 2020
- Drug-Eluting Stent Versus Drug-Coated Balloon Revascularization in Patients With Femoropopliteal Arterial Disease
Journal of the American College of Cardiology · 2019
- Paclitaxel-Coated Zilver PTX Drug-Eluting Stent Treatment Does Not Result in Increased Long-Term All-Cause Mortality Compared to Uncoated Devices
CardioVascular and Interventional Radiology · 2019
- Zilver PTX RCT mortality analysis: no difference in long-term mortality rate for Zilver PTX drug-eluting stent compared to PTA/BMS
CVIR Endovascular · 2019
- Zilver PTX Post-market Surveillance Study of Paclitaxel-Eluting Stents for Treating Femoropopliteal Artery Disease in Japan: 2-Year Results
CardioVascular and Interventional Radiology · 2018
- Long-Term Effectiveness of the Zilver PTX Drug-Eluting Stent for Femoropopliteal Peripheral Artery Disease in Patients with No Patent Tibial Runoff Vessels—Results from the Zilver PTX Japan Post-Market Surveillance Study
Journal of Vascular and Interventional Radiology · 2017
- Impact of Chronic Renal Failure on Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Artery Disease: Subgroup Analysis from Zilver PTX Post-Market Surveillance Study in Japan
CardioVascular and Interventional Radiology · 2017
- A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease
Journal of Endovascular Therapy · 2017
- CardioVascular and Interventional Radiology×4
- Journal of Clinical and Translational Science×3
- JACC: Cardiovascular Interventions×2
- Journal of Endovascular Therapy×2
- Journal of the American College of Cardiology×1
- Corey A. Kalbaugh
Medicine · Indiana University
- Said Atway
Medicine · The Ohio State University
- Mitchel R. Stacy
Medicine · The Ohio State University
- Michael R. Go
Medicine · The Ohio State University
- Matthew A. Corriere
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 20, 2026.
Claim or correct this profile